Exodus Point Capital Management, LP Cullinan Oncology, Inc. Transaction History
Exodus Point Capital Management, LP
- $13.1 Billion
- Q1 2024
A detailed history of Exodus Point Capital Management, LP transactions in Cullinan Oncology, Inc. stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 16,347 shares of CGEM stock, worth $266,619. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,347
Previous 35,759
54.29%
Holding current value
$266,619
Previous $324,000
13.89%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding CGEM
# of Institutions
118Shares Held
42.8MCall Options Held
12.6KPut Options Held
4.9K-
Bio Impact Capital LLC Cambridge, MA7.65MShares$125 Million21.33% of portfolio
-
Chi Advisors LLC New York, NY3.41MShares$55.7 Million15.23% of portfolio
-
Bvf Inc San Francisco, CA3.2MShares$52.1 Million1.63% of portfolio
-
Blue Owl Capital Holdings LP New York, NY2.92MShares$47.7 Million13.21% of portfolio
-
Franklin Resources Inc San Mateo, CA2.7MShares$44 Million0.02% of portfolio
About Cullinan Oncology, Inc.
- Ticker CGEM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,612,200
- Market Cap $744M
- Description
- Cullinan Oncology Inc., a biopharmaceutical company, focuses on developing a pipeline of targeted oncology and immuno-oncology therapies for cancer patients in the United States. The company's lead candidate is the CLN-081, an orally available small molecule that is in a Phase I/IIa dose escalation and expansion trial for treating patients with ...